Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance.

Autor: Plaza-Menacho, I1,2, Morandi, A1, Robertson, D1, Pancholi, S1, Drury, S1,3, Dowsett, M1,3, Martin, L-A1, Isacke, C M1 clare.isacke@icr.ac.uk
Zdroj: Oncogene. 8/19/2010, Vol. 29 Issue 33, p4648-4657. 10p. 6 Color Photographs.
Databáze: Academic Search Ultimate